Answers are grounded in this paper and cite their sources.
Limited data are available on long-term weight loss achieved with semaglutide or liraglutide for type 2 diabetes (T2D) or obesity in clinical practice.
No takes yet. Share an insight, caveat, or question.
Gasoyan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: